Aventis to buy Universal Medicare's nutraceutical business

Published on Wed, Aug 24, 2011 at 09:38 |  Source : Moneycontrol.com

Updated at Wed, Aug 24, 2011 at 13:16  

2865 Investors following Aventis Pharma. Share this News with them.
0
0
Share on Tumblr
Aventis to buy Universal Medicare's nutraceutical business

ALSO READ

Moneycontrol Bureau

Sanofi group company Aventis Pharma has entered into an agreement to acquire Universal Medicare's business of marketing and distribution of nutraceutical formulations in India.

Mumbai-based Universal Medicare manufactures, markets and distributes branded nutraceutical formulations in India through their sales and marketing infrastructure, and the business had turnover of about Rs 110 crore for year ended March 31.

Under the deal, Universal Medicare will manufacture the products that Aventis Pharma will acquire. Around 750 employees will also move to Aventis Pharma, the company said Wednesday.

Aventis Pharma shares surged following the announcement, and at 9:30 hrs were traded up 3.3% at Rs 2,110 on NSE.

"This strategic acquisition will allow Aventis Pharma and Sanofi Group to reach out to large sections of India's population through a broad offering comprising of pharmaceuticals, vaccines and now nutraceuticals," said Dr Shailesh Ayyangar, managing director of Aventis Pharma and vice president - south Asia, Sanofi.

The acquisition is expected to close in the fourth quarter of 2011, Aventis said.

Universal Medicare's portfolio of over 40 branded formulations represent key categories within the nutraceutical market, that are primarily anti-oxidants, vitamins, and mineral supplements, anti-arthritics, anti-osteoporotics, liver tonics and other nutrients.


Nachiket Kelkar
nachiket.kelkar@network18online.com

  

Trending News

Business News

Recharge your Tata Docomo prepaid card by tweeting at them
IT dept freezes Kingfisher Airlines' bank a/c, again "IT dept freezes Kingfisher Airlines' bank a/c, again"

Team Anna sticks to claims as PM hits back strongly

MS Sahoo Says On CNBC-TV18 New Guidelines Are An Improvement Over The Old Ones

The latest earning numbers FIRST on CNBC-TV18
Videos

May 29 2012, 12:19

Expect Tata Motors Q4 PAT at Rs 4200 cr: StanChart

- in Brokerage Results Estimates

Interviews

May 29 2012, 22:37 | Source: CNBC-TV18

Due diligence not applied in Reebok 2010 probe: Assocham  

May 29 2012, 17:34 | Source: CNBC-TV18

Will raise Rs 250cr via ECB route next year: Hind Copper  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!